Summary
- Main use
- Peritoneal dialysis treatment in patients with chronic renal failure
- Who receives it
- Adults · Children
- Adult administration
- For intraperitoneal administration only; do not use intravenously. This product is for single use only. Extraneal is recommended for use during the longest dwell period (e.g., generally at night for continuous ambulatory peritoneal dialysis and during the day for automated peritoneal dialysis). Adults: Replace the existing peritoneal dialysis solution for one exchange per 24 hours using peritoneal dialysis. Older adults: Same as adults. The peritoneal dialysis procedure must be performed aseptically. Infuse the prescribed volume at a rate comfortable for the patient, over approximately 10-20 minutes. Dose adjustment is as prescribed by the physician. The infusion volume for an adult patient of average build should not exceed 2.0L. If this volume causes abdominal tension, use 1.5L. The recommended dwell time is 6~12 hours for CAPD and 14~16 hours for APD. Drain by gravity at a rate comfortable for the patient. Examine the drained fluid for fibrin or cloudiness, which may indicate infection. The treating physician should adjust the treatment method, frequency, dose, dialysis time, and duration according to the patient's condition.
- Child administration
- Children: Not recommended for children 18 years of age or younger because safety and efficacy have not been evaluated.
Ingredients
- Icodextrin75g / 1000mL
- Magnesium Chloride0.0508g / 1000mL
- Sodium Lactate Solution 60%7.5g / 1000mL
- Calcium Chloride0.257g / 1000mL
- Sodium Chloride5.38g / 1000mL
- Importer
- VANTIVE KOREA INCORPORATED
Efficacy & effects
Peritoneal dialysis treatment in patients with chronic renal failure
View approved original textHide original text
This medication is used to extend the peritoneal dialysis treatment period for chronic kidney failure patients who have difficulty with ultrafiltration using glucose solutions. During Continuous Ambulatory Peritoneal Dialysis (CAPD) or Automated Peritoneal Dialysis (APD), this medication is administered once daily as a substitute for glucose dialysis solutions to enhance treatment outcomes. It helps improve the convenience and effectiveness of treatment for patients.
How it is given
Adult administration
For intraperitoneal administration only; do not use intravenously. This product is for single use only. Extraneal is recommended for use during the longest dwell period (e.g., generally at night for continuous ambulatory peritoneal dialysis and during the day for automated peritoneal dialysis). Adults: Replace the existing peritoneal dialysis solution for one exchange per 24 hours using peritoneal dialysis. Older adults: Same as adults. The peritoneal dialysis procedure must be performed aseptically. Infuse the prescribed volume at a rate comfortable for the patient, over approximately 10-20 minutes. Dose adjustment is as prescribed by the physician. The infusion volume for an adult patient of average build should not exceed 2.0L. If this volume causes abdominal tension, use 1.5L. The recommended dwell time is 6~12 hours for CAPD and 14~16 hours for APD. Drain by gravity at a rate comfortable for the patient. Examine the drained fluid for fibrin or cloudiness, which may indicate infection. The treating physician should adjust the treatment method, frequency, dose, dialysis time, and duration according to the patient's condition.
Child administration
Children: Not recommended for children 18 years of age or younger because safety and efficacy have not been evaluated.
Precautions
This medication should not be used in patients who are allergic to starch polymers or icodextrin. Patients with hypersensitivity to maltose or isomaltose should also not use this medication. Patients with poor condition after abdominal surgery or problems with peritoneal function, patients with glycogen storage disease, diaphragm injury, etc., should not be administered this medication. Lactate metabolism patients, severe lactic acidosis patients, and patients with uremia-related hemorrhagic diathesis are also excluded from administration. Pregnant or breastfeeding women, children, and patients with acute kidney failure should use this medication with caution, and patients with specific peritoneal and abdominal diseases also require attention. This medication is used only for peritoneal dialysis, and fluid balance must be accurately recorded and weight changes carefully monitored. In particular, the patient's condition must be meticulously monitored to avoid excess or deficiency of fluid. During dialysis, protein, amino acids, and vitamins may be lost, so supplementation therapy should be performed according to the physician's prescription if necessary. Diabetic patients who require blood sugar control must regularly check their blood sugar levels and adjust their insulin doses, and they should use a method that does not interact with maltose when measuring blood sugar. Various adverse reactions such as peritonitis, infections, skin rashes, blood pressure changes, gastrointestinal symptoms, and neurological abnormalities may occur, so symptoms should be immediately reported to medical personnel. This medication may interact with other drugs, so if other medications are being taken, it is essential to consult with a healthcare professional. Pregnant or breastfeeding women should avoid using this medication unless under special circumstances, and its use in pediatric patients is not recommended. In case of overdose, medical personnel should be notified immediately and appropriate measures should be taken, and this medication must always be used under the supervision of a physician. When exchanging peritoneal dialysis fluid, aseptic technique must be strictly adhered to, and the solution must be appropriately warmed before use; discolored or damaged solutions should not be used. Keep out of reach of children and discard any leftover solutions after use.
Side effects
- Influenza
- abscess
- infection
- anemia
- leukocytosis
- eosinophilia
- dehydration
- decreased fluid volume
- hypoglycemia
- hyponatremia
Show 171 moreCollapse
- hyperglycemia
- fluid overload
- loss of appetite
- hypochloremia
- hypomagnesemia
- hypoalbuminemia
- abnormal behavior
- anxiety
- neuroirritability
- dizziness
- headache
- hyperactivity
- sensory disturbances
- ageusia
- tinnitus
- cardiovascular disease
- tachycardia
- hypotension
- hypertension
- orthostatic hypotension
- pulmonary edema
- dyspnea
- cough
- hiccups
- lung disorders
- abdominal pain
- abdominal distension
- intestinal obstruction
- peritonitis
- hemorrhagic peritoneal effusion
- diarrhea
- gastric ulcer
- gastritis
- gastrointestinal disorders
- vomiting
- constipation
- dyspepsia
- nausea
- dry mouth
- bloating
- exfoliative dermatitis
- rash
- pruritus
- urticaria
- vesicular dermatitis
- psoriasis
- maculopapular rash
- skin ulcers
- eczema
- nail disorders
- skin disorders
- dry skin
- skin discoloration
- bone pain
- muscle cramps
- myalgia
- neck pain
- kidney pain
- peripheral edema
- asthenia
- chest pain
- catheter-related complications
- facial swelling
- edema
- pain
- decreased urine output
- abnormal laboratory results
- increased alanine aminotransferase
- increased aspartate aminotransferase
- increased serum alkaline phosphatase
- abnormal liver function tests
- weight loss
- weight gain
- injury
- abdominal pain
- turbid drainage
- fever
- bleeding
- catheter-associated infection
- catheter blockage
- shoulder pain
- decreased blood volume
- increased blood volume
- hypertension
- hypotension
- dehydration
- edema
- constipation
- abdominal hernia
- appetite reduction
- dyspepsia
- vomiting
- nausea
- dizziness
- fatigue
- headache
- itching
- abnormal laboratory values
- loss of appetite
- fatigue
- visual disturbances
- electrolyte imbalance
- hypokalemia
- hypocalcemia
- hypercalcemia
- increased blood volume
- decreased blood volume
- hypotension/hypertension
- muscle cramps
- imbalance syndrome
- turbid drainage
- aseptic peritonitis
- syncope
- shortness of breath
- weakness
- rash
- itching
- skin shedding
- toxic epidermal necrolysis
- erythema multiforme
- angioedema
- generalized urticaria
- toxic skin rash
- facial swelling
- orbital edema
- exfoliative rash
- skin peeling
- itchy rash
- rash
- skin ulcers
- drug rash
- erythema
- nail loss
- skin fissures
- vesicles
- arthralgia
- lumbago
- musculoskeletal pain
- penile edema
- scrotal edema
- discomfort
- fever
- chills
- malaise
- reduced drug effect
- ineffective medication
- redness at catheter site
- inflammation at catheter site
- infusion-related reactions
- interactions with infusion devices
- sepsis
- thrombocytopenia
- leukopenia
- vasculitis
- serum sickness
- hypersensitivity
- hypoglycemic shock
- fluid overload
- fluid imbalance
- hypoglycemic coma
- burning sensation
- blurred vision
- bronchospasm
- stridor
- sclerosing encapsulating peritonitis
- ascites
- inguinal hernia
- abdominal discomfort
- apnea
- lung disease
- exacerbated cough
Not everyone experiences these, and they can vary from person to person.
Storage
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, and the temperature should be maintained below 30 degrees. Storing it this way helps to preserve the medication's efficacy and prevent degradation.
Appearance and packaging
Appearance
This medication is a transparent peritoneal dialysis solution, light yellow in color, contained in a colorless transparent plastic bag. 2L/bag (Automated Peritoneal Dialysis) is connected in the order of infusion line, inner plug, connector, and rubber ring to the peritoneal dialysis solution bag.
Package unit
2000ml/2 bags, 2000ml/bag
Questions about this medicine
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.